Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-19 4:29 pm Purchase | 13G | Cyteir Therapeutics Inc. CYT | BML Investment Partners L.P. | 3,818,464 10.600% | 348,456 (+10.04%) | View |
| 2024-03-12 4:16 pm Purchase | 13D | Cyteir Therapeutics Inc. CYT | GAMCO INVESTORS INC. GBL | 1,511,035 4.200% | 193,950 (+14.73%) | View |
| 2024-02-14 7:36 pm Purchase | 13G | Cyteir Therapeutics Inc. CYT | Lightstone Ventures II L.P. | 2,472,565 6.900% | 2,472,565 (New Position) | View |
| 2024-02-14 4:21 pm Sale | 13G | Cyteir Therapeutics Inc. CYT | BAKER BROS. ADVISORS LP | 0 0.000% | -2,492,118 (Position Closed) | View |
| 2024-02-14 4:05 pm Purchase | 13G | Cyteir Therapeutics Inc. CYT | Newtyn Management LLC | 3,021,500 8.400% | 3,021,500 (New Position) | View |
| 2024-02-13 7:14 pm Sale | 13G | Cyteir Therapeutics Inc. CYT | Avidity Partners Management LP | 0 0.000% | -1,795,800 (Position Closed) | View |
| 2024-02-09 4:28 pm Purchase | 13D | Cyteir Therapeutics Inc. CYT | GAMCO INVESTORS INC. GBL | 1,317,085 3.660% | 207,035 (+18.65%) | View |
| 2024-02-07 1:40 pm Purchase | 13G | Cyteir Therapeutics Inc. CYT | BML Investment Partners L.P. | 3,470,008 9.600% | 734,035 (+26.83%) | View |
| 2024-01-19 09:30 am Purchase | 13G | Cyteir Therapeutics Inc. CYT | HEDGEHOG CAPITAL LLC | 2,518,521 7.000% | 304,603 (+13.76%) | View |
| 2023-11-03 5:00 pm Purchase | 13G | Cyteir Therapeutics Inc. CYT | HEDGEHOG CAPITAL LLC | 2,213,918 6.100% | 2,213,918 (New Position) | View |
| 2023-10-19 4:07 pm Purchase | 13D | Cyteir Therapeutics Inc. CYT | GAMCO INVESTORS INC. GBL | 1,110,050 3.070% | 1,110,050 (New Position) | View |
| 2023-08-03 5:02 pm Sale | 13D | Cyteir Therapeutics Inc. CYT | Novo Holdings A/S | 1,547,136 4.400% | -1,525,000 (-49.64%) | View |
| 2023-07-26 4:58 pm Sale | 13D | Cyteir Therapeutics Inc. CYT | Novo Holdings A/S | 3,072,136 8.700% | -868,277 (-22.04%) | View |
| 2023-07-10 10:20 am Sale | 13G | Cyteir Therapeutics Inc. CYT | FMR LLC | 827,867 2.331% | -2,080,509 (-71.54%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | Cyteir Therapeutics Inc. CYT | BAKER BROS. ADVISORS LP | 2,492,118 7.000% | 2,492,118 (New Position) | View |
| 2023-02-14 2:42 pm Sale | 13G | Cyteir Therapeutics Inc. CYT | Avidity Partners Management LP | 1,795,800 5.100% | -53,738 (-2.91%) | View |
| 2023-02-09 09:59 am Sale | 13G | Cyteir Therapeutics Inc. CYT | FMR LLC | 2,908,376 8.206% | -1,140,617 (-28.17%) | View |
| 2023-02-09 09:42 am Sale | 13G | Cyteir Therapeutics Inc. CYT | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -1,872,421 (Position Closed) | View |
| 2023-02-02 4:31 pm Sale | 13G | Cyteir Therapeutics Inc. CYT | Osage University GP II LLC | 2,459,572 6.900% | -15,000 (-0.61%) | View |
| 2023-01-26 4:01 pm Purchase | 13G | Cyteir Therapeutics Inc. CYT | BML Investment Partners L.P. | 2,735,973 7.700% | 2,735,973 (New Position) | View |